Breaking News Instant updates and real-time market news.

ADDYY

Adidas

$0.00 /

+ (+0.00%)

06:44
04/09/20
04/09
06:44
04/09/20
06:44

Adidas upgraded to Buy from Hold at HSBC

HSBC analyst Erwan Rambourg upgraded Adidas to Buy from Hold with a lower price target of EUR 280, down from EUR 330. The analyst notes that the company's 2020 performance will be seriously impacted by the combination of pre-virus issues that include tariffs, FX, and investments, as well as COVID-19-related pressures, but he sees the valuation on the stock becoming compelling. Rambourg is also positive on the relatively better Asia exposure of Adidas.

ADDYY Adidas
$0.00 /

+ (+0.00%)

04/02/20 DZ Bank
Adidas downgraded to Hold from Buy at DZ Bank
03/17/20 RBC Capital
Adidas price target lowered to EUR 245 from EUR 290 at RBC Capital
03/17/20 Exane BNP Paribas
Adidas upgraded to Outperform from Neutral at Exane BNP Paribas
03/12/20 JPMorgan
JPMorgan backs Neutral on Adidas after FY19 results

TODAY'S FREE FLY STORIES

Hot Stocks
Ovid Therapeutics trading resumes  09:45
05/26/20
05/26
09:45
05/26/20
09:45
OVID

Ovid Therapeutics

$6.25 /

+0.4 (+6.84%)

 
ShowHide Related Items >><<
OVID Ovid Therapeutics
$6.25 /

+0.4 (+6.84%)

OVID Ovid Therapeutics
$6.25 /

+0.4 (+6.84%)

05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
05/07/20 Piper Sandler
Ovid's gaboxadol data in Fragile X 'promising,' says Piper Sandler
03/30/20 Piper Sandler
Piper says Ovid data suggests potential use for soticlestat in CDD/Dup15q
09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
OVID Ovid Therapeutics
$6.25 /

+0.4 (+6.84%)

Options
JD.com call volume above normal and directionally bullish » 09:45
05/26/20
05/26
09:45
05/26/20
09:45
JD

JD.com

$52.45 /

+2.57 (+5.15%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JD JD.com
$52.45 /

+2.57 (+5.15%)

JD JD.com
$52.45 /

+2.57 (+5.15%)

05/18/20 Benchmark
JD.com price target raised to $66 from $60 at Benchmark
05/18/20 Goldman Sachs
JD.com price target raised to $59 from $52 at Goldman Sachs
05/18/20 Stifel
JD.com price target raised to $50 from $43 at Stifel
05/18/20 Citi
JD.com price target raised to $60 from $56 at Citi
JD JD.com
$52.45 /

+2.57 (+5.15%)

JD JD.com
$52.45 /

+2.57 (+5.15%)

JD JD.com
$52.45 /

+2.57 (+5.15%)

JD JD.com
$52.45 /

+2.57 (+5.15%)

General news
Consumer Confidence to be reported at 10:00 » 09:45
05/26/20
05/26
09:45
05/26/20
09:45

May Consumer Confidence…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
New Home Sales to be reported at 10:00 » 09:45
05/26/20
05/26
09:45
05/26/20
09:45

April New Home Sales will…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Haverty Furniture Companies trading halted, volatility trading pause  09:44
05/26/20
05/26
09:44
05/26/20
09:44
 
Conference/Events
Roth Capital biotech analysts to hold an analyst/industry conference call » 09:42
05/26/20
05/26
09:42
05/26/20
09:42
AKRO

Akero Therapeutics

$24.21 /

+ (+0.00%)

, ALT

Altimmune

$6.94 /

+ (+0.00%)

, ENTA

Enanta

$55.12 /

+ (+0.00%)

, GLMD

Galmed

$5.80 /

+ (+0.00%)

, GNFT

Genfit

$5.24 /

+ (+0.00%)

, HEPA

Hepion Pharmaceuticals

$1.99 /

+ (+0.00%)

, ICPT

Intercept

$80.54 /

+ (+0.00%)

, MDGL

Madrigal Pharmaceuticals

$125.83 /

+ (+0.00%)

, NGM

NGM Biopharmaceuticals

$20.18 /

+ (+0.00%)

Biotech Analysts, along…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

ALT Altimmune
$6.94 /

+ (+0.00%)

ENTA Enanta
$55.12 /

+ (+0.00%)

GNFT Genfit
$5.24 /

+ (+0.00%)

HEPA Hepion Pharmaceuticals
$1.99 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

MDGL Madrigal Pharmaceuticals
$125.83 /

+ (+0.00%)

NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/02/20 H.C. Wainwright
Akero Therapeutics initiated with a Buy at H.C. Wainwright
02/13/20 Roth Capital
Akero Therapeutics price target raised to $43 from $34 at Roth Capital
02/10/20 Canaccord
Akero Therapeutics initiated with a Buy at Canaccord
ALT Altimmune
$6.94 /

+ (+0.00%)

05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
02/24/20
Fly Intel: Top five analyst initiations
ENTA Enanta
$55.12 /

+ (+0.00%)

03/17/20 Baird
Baird upgrades 'defensive' Enanta, sees 'real COVID-19 potential'
03/17/20 Baird
Enanta upgraded to Outperform from Neutral at Baird
02/07/20 Roth Capital
Enanta is 'undervalued and underappreciated,' says Roth Capital
11/22/19
Fly Intel: Top five analyst downgrades
GLMD Galmed
$5.80 /

+ (+0.00%)

05/22/20
Fly Intel: Top five analyst downgrades
05/22/20 B. Riley FBR
B. Riley FBR downgrades Galmed, cuts target to $8 from $11
05/22/20 B. Riley FBR
Galmed downgraded to Neutral from Buy at B. Riley FBR
05/15/20 H.C. Wainwright
Galmed price target lowered to $29 from $34 at H.C. Wainwright
GNFT Genfit
$5.24 /

+ (+0.00%)

05/22/20 B. Riley FBR
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR
05/13/20 Bryan Garnier
Genfit downgraded to Neutral from Buy at Bryan Garnier
05/13/20 Kepler Cheuvreux
Genfit downgraded to Reduce from Buy at Kepler Cheuvreux
05/12/20 B. Riley FBR
Genfit downgraded to Neutral from Buy at B. Riley FBR
HEPA Hepion Pharmaceuticals
$1.99 /

+ (+0.00%)

03/20/20 Roth Capital
Roth Capital says Hepion's CRV431 could be used in COVID-19 treatment
11/22/19 Brookline
Hepion Pharmaceuticals initiated with a Buy at Brookline
11/07/19
Fly Intel: Top analyst initiations
11/07/19 Roth Capital
Hepion Pharmaceuticals initiated with a Buy at Roth Capital
ICPT Intercept
$80.54 /

+ (+0.00%)

05/22/20 B. Riley FBR
Intercept weakness on 'slight' delay should be bought, says B. Riley FBR
05/22/20 Raymond James
Intercept downgraded at Raymond James after OCA NDA is postponed
05/22/20 Raymond James
Intercept downgraded to Outperform from Strong Buy at Raymond James
05/22/20 Stifel
Intercept uncertainty, lack of clarity in NASH to hurt sentiment, says Stifel
MDGL Madrigal Pharmaceuticals
$125.83 /

+ (+0.00%)

05/22/20 B. Riley FBR
Madrigal Pharmaceuticals price target raised to $174 from $134 at B. Riley FBR
05/08/20 H.C. Wainwright
Madrigal Pharmaceuticals price target lowered to $168 from $215 at H.C. Wainwright
05/06/20 Goldman Sachs
Goldman says Novo Nordisk NASH data a 'clear positive' for Intercept
05/05/20 Chardan
Madrigal Pharmaceuticals initiated with a Buy at Chardan
NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

05/06/20 Stifel
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/31/20 H.C. Wainwright
Akero's BALANCED study results 'quite impressive,' says H.C. Wainwright
03/27/20 Citi
NGM Biopharmaceuticals price target lowered to $28 from $34 at Citi
AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

ALT Altimmune
$6.94 /

+ (+0.00%)

ENTA Enanta
$55.12 /

+ (+0.00%)

GLMD Galmed
$5.80 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

MDGL Madrigal Pharmaceuticals
$125.83 /

+ (+0.00%)

NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

GNFT Genfit
$5.24 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

ALT Altimmune
$6.94 /

+ (+0.00%)

GNFT Genfit
$5.24 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

MDGL Madrigal Pharmaceuticals
$125.83 /

+ (+0.00%)

NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

AKRO Akero Therapeutics
$24.21 /

+ (+0.00%)

ALT Altimmune
$6.94 /

+ (+0.00%)

ICPT Intercept
$80.54 /

+ (+0.00%)

NGM NGM Biopharmaceuticals
$20.18 /

+ (+0.00%)

Hot Stocks
Ovid Therapeutics trading halted, volatility trading pause  09:40
05/26/20
05/26
09:40
05/26/20
09:40
OVID

Ovid Therapeutics

$5.85 /

+ (+0.00%)

 
ShowHide Related Items >><<
OVID Ovid Therapeutics
$5.85 /

+ (+0.00%)

OVID Ovid Therapeutics
$5.85 /

+ (+0.00%)

05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
05/07/20 Piper Sandler
Ovid's gaboxadol data in Fragile X 'promising,' says Piper Sandler
03/30/20 Piper Sandler
Piper says Ovid data suggests potential use for soticlestat in CDD/Dup15q
09/24/19 Citi
Ovid Therapeutics price target raised to $10 from $8 at Citi
OVID Ovid Therapeutics
$5.85 /

+ (+0.00%)

Hot Stocks
Starboard seeks votes for GCP board slate in letter to holders » 09:40
05/26/20
05/26
09:40
05/26/20
09:40
GCP

GCP Applied Technologies

$19.17 /

+ (+0.00%)

Starboard Value LP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GCP GCP Applied Technologies
$19.17 /

+ (+0.00%)

GCP GCP Applied Technologies
$19.17 /

+ (+0.00%)

03/23/20 Jefferies
Jefferies downgrades 10 'lower conviction' Chemicals stocks to Hold
03/23/20 Jefferies
GCP Applied Technologies downgraded to Hold from Buy at Jefferies
GCP GCP Applied Technologies
$19.17 /

+ (+0.00%)

Periodicals
Moelis in talks to represent Latam bondholders in bankrtupcy, Reuters reports » 09:38
05/26/20
05/26
09:38
05/26/20
09:38
LTM

Latam Airlines

$2.57 /

-0.13 (-4.81%)

, MC

Moelis

$29.77 /

+0.37 (+1.26%)

Moelis & Co (MC) is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

09:30 Today Raymond James
Latam Airlines downgraded to Underperform from Outperform at Raymond James
05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
04/24/20 Morgan Stanley
Latam Airlines downgraded to Underweight from Equal Weight at Morgan Stanley
04/16/20 HSBC
Latam Airlines upgraded to Buy from Hold at HSBC
MC Moelis
$29.77 /

+0.37 (+1.26%)

04/14/20 UBS
Moelis downgraded to Sell from Neutral at UBS
03/23/20 JPMorgan
JPMorgan downgrades Moelis to Neutral on slowing M&A risk
03/23/20 JPMorgan
Moelis downgraded to Neutral from Overweight at JPMorgan
02/06/20 Buckingham
Moelis price target raised to $41 from $39 at Buckingham
MC Moelis
$29.77 /

+0.37 (+1.26%)

LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

MC Moelis
$29.77 /

+0.37 (+1.26%)

LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

MC Moelis
$29.77 /

+0.37 (+1.26%)

LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

Upgrade
GTT Communications upgraded to Outperform from Market Perform at Raymond James » 09:36
05/26/20
05/26
09:36
05/26/20
09:36
GTT

GTT Communications

$9.03 /

-0.02 (-0.22%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
05/11/20 SunTrust
GTT Communications downgraded to Hold from Buy at SunTrust
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
04/17/20 Oppenheimer
GTT Communications downgraded to Perform from Outperform at Oppenheimer
GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

GTT GTT Communications
$9.03 /

-0.02 (-0.22%)

Recommendations
Zillow price target raised to $66 from $39 at DA Davidson » 09:36
05/26/20
05/26
09:36
05/26/20
09:36
ZG

Zillow

$56.11 /

+2.58 (+4.82%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZG Zillow
$56.11 /

+2.58 (+4.82%)

ZG Zillow
$56.11 /

+2.58 (+4.82%)

05/12/20 Wedbush
Zillow price target raised to $50 from $30 at Wedbush
05/08/20 Craig-Hallum
Zillow price target lowered to $45 from $60 at Craig-Hallum
05/06/20 Needham
Needham says checks indicate Zillow discounted May Premier Agent by 20%-50%
04/20/20 Stephens
Stephens ups CoreLogic, downgrades two others in real estate services shake-up
ZG Zillow
$56.11 /

+2.58 (+4.82%)

Hot Stocks
Immunovant Inc (Units) trading resumes  09:36
05/26/20
05/26
09:36
05/26/20
09:36
 
Upgrade
Uranium Participation upgraded to Buy from Hold at TD Securities » 09:35
05/26/20
05/26
09:35
05/26/20
09:35
URPTF

Uranium Participation

$0.00 /

+ (+0.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
URPTF Uranium Participation
$0.00 /

+ (+0.00%)

09:32 Today TD Securities
Correction: Uranium Participation upgraded to Buy from Hold at TD Securities
07:20 Today TD Securities
Uranium Participation downgraded to Buy from Hold at TD Securities
05/20/20 Canaccord
Uranium Participation initiated with a Buy at Canaccord
Conference/Events
The Cato Institute to hold a webinar » 09:35
05/26/20
05/26
09:35
05/26/20
09:35

Live Online Policy Form…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Qurate Retail Inc (Series B Stock) trading resumes  09:35
05/26/20
05/26
09:35
05/26/20
09:35
 
Hot Stocks
Texas Capital trading resumes  09:35
05/26/20
05/26
09:35
05/26/20
09:35
TCBI

Texas Capital

$28.54 /

-0.06 (-0.21%)

 
ShowHide Related Items >><<
TCBI Texas Capital
$28.54 /

-0.06 (-0.21%)

TCBI Texas Capital
$28.54 /

-0.06 (-0.21%)

09:04 Today Keefe Bruyette
Texas Capital downgraded to Market Perform from Outperform at Keefe Bruyette
08:08 Today Piper Sandler
Texas Capital downgraded to Neutral from Overweight at Piper Sandler
03/06/20 SunTrust
SunTrust cuts price targets on Banks amid lower interest rate environment
02/20/20 UBS
Texas Capital upgraded to Neutral from Sell at UBS
TCBI Texas Capital
$28.54 /

-0.06 (-0.21%)

Recommendations
BioMarin among Sanofi's most intriguing potential targets, says RBC Capital » 09:33
05/26/20
05/26
09:33
05/26/20
09:33
BMRN

BioMarin

$97.50 /

+2.67 (+2.82%)

, SNI

Scripps Networks

$90.01 /

+ (+0.00%)

, REGN

Regeneron

$569.94 /

+8.55 (+1.52%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BMRN BioMarin
$97.50 /

+2.67 (+2.82%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

BMRN BioMarin
$97.50 /

+2.67 (+2.82%)

05/22/20 Jefferies
Jefferies adds six names to Franchise Picks list, including BioMarin and TJX
05/08/20 Canaccord
BioMarin price target raised to $119 from $108 at Canaccord
05/01/20 Jefferies
Jefferies says valrox, vosoritide uptake may be faster than other BioMarin drugs
04/29/20 Piper Sandler
BioMarin guidance cut 'transient', says Piper Sandler
SNI Scripps Networks
$90.01 /

+ (+0.00%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

09:09 Today Piper Sandler
Piper remains buyer of Regeneron, ups target to $630 on buyback accretion
08:24 Today SVB Leerink
Sanofi overhang removed, Regeneron capital structure improving, says SVB Leerink
06:29 Today Wells Fargo
Regeneron upgraded to Overweight at Wells Fargo on EYLEA Survey
04:44 Today Wells Fargo
Regeneron upgraded to Overweight from Equal Weight at Wells Fargo
BMRN BioMarin
$97.50 /

+2.67 (+2.82%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

  • 27
    May
REGN Regeneron
$569.94 /

+8.55 (+1.52%)

BMRN BioMarin
$97.50 /

+2.67 (+2.82%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

BMRN BioMarin
$97.50 /

+2.67 (+2.82%)

REGN Regeneron
$569.94 /

+8.55 (+1.52%)

Conference/Events
Federal Reserve Bank of Minneapolis to hold a virtual event » 09:33
05/26/20
05/26
09:33
05/26/20
09:33
MRK

Merck

$76.37 /

-0.17 (-0.22%)

"Living in a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$76.37 /

-0.17 (-0.22%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

05/20/20 JonesTrading
Merck collaboration positions Surface Oncology well, says JonesTrading
04/27/20 SVB Leerink
Clovis downgraded to Underperform at SVB Leerink as prostate opportunity fades
04/06/20 Raymond James
NGM Biopharmaceuticals initiated with a Strong Buy at Raymond James
03/23/20 Mizuho
Merck business disruptions have been modest, says Mizuho
MRK Merck
$76.37 /

-0.17 (-0.22%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

MRK Merck
$76.37 /

-0.17 (-0.22%)

Hot Stocks
Immunovant Inc (Units) trading halted, volatility trading pause  09:31
05/26/20
05/26
09:31
05/26/20
09:31
 
Hot Stocks
Qurate Retail Inc (Series B Stock) trading halted, volatility trading pause  09:30
05/26/20
05/26
09:30
05/26/20
09:30
 
Conference/Events
KeyBanc to hold a virtual conference » 09:30
05/26/20
05/26
09:30
05/26/20
09:30

Capital Markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Texas Capital trading halted, volatility trading pause  09:30
05/26/20
05/26
09:30
05/26/20
09:30
TCBI

Texas Capital

$28.54 /

-0.06 (-0.21%)

 
ShowHide Related Items >><<
TCBI Texas Capital
$28.54 /

-0.06 (-0.21%)

TCBI Texas Capital
$28.54 /

-0.06 (-0.21%)

09:04 Today Keefe Bruyette
Texas Capital downgraded to Market Perform from Outperform at Keefe Bruyette
08:08 Today Piper Sandler
Texas Capital downgraded to Neutral from Overweight at Piper Sandler
03/06/20 SunTrust
SunTrust cuts price targets on Banks amid lower interest rate environment
02/20/20 UBS
Texas Capital upgraded to Neutral from Sell at UBS
TCBI Texas Capital
$28.54 /

-0.06 (-0.21%)

Downgrade
Latam Airlines downgraded to Underperform from Outperform at Raymond James » 09:30
05/26/20
05/26
09:30
05/26/20
09:30
LTM

Latam Airlines

$2.57 /

-0.13 (-4.81%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

05/04/20 Deutsche Bank
Avianca downgraded to Sell from 50c price target at Deutsche Bank
04/24/20 Morgan Stanley
Latam Airlines downgraded to Underweight from Equal Weight at Morgan Stanley
04/16/20 HSBC
Latam Airlines upgraded to Buy from Hold at HSBC
04/13/20 Bradesco
Latam Airlines downgraded to Underperform from Neutral at Bradesco
LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

LTM Latam Airlines
$2.57 /

-0.13 (-4.81%)

Initiation
Providence Service initiated with an Outperform at Barrington » 09:29
05/26/20
05/26
09:29
05/26/20
09:29
PRSC

Providence Service

$75.60 /

+5.94 (+8.53%)

Barrington analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRSC Providence Service
$75.60 /

+5.94 (+8.53%)

Hot Stocks
U.S. Gold receives proposal to upgrade Copper King PEA to a PFS » 09:29
05/26/20
05/26
09:29
05/26/20
09:29
USAU

U.S. Gold

$5.98 /

+0.33 (+5.84%)

U.S. Gold announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USAU U.S. Gold
$5.98 /

+0.33 (+5.84%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.